Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

TNXPTNXP
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in TONIX PHARMACEUTICALS HOLDIN

Yes. Bank of America holds 60,977 shares of TNXP (Tonix Pharmaceuticals Holdin), worth $778,067, as of its Q2 2026 13F filing. It increased the position by 19 shares from Q1 2026. Bank of America has held TNXP since Q1 2025, across 6 quarterly 13F filings.

Current Value

$778,067

Current Shares

60,977

Total Value Change

+$675,107

Total Shares Change

+55,217

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
60,977
+0.0%
$778,0670.0%$12.76
25
2026-Q1
Increased
60,958
+101.1%
$838,1730.0%$13.75
40
2025-Q4
Increased
30,314
+551.8%
$473,5050.0%$15.62
26
2025-Q3
Increased
4,651
+32.7%
$112,3680.0%$24.16
19
2025-Q2
Decreased
3,505
-39.1%
$126,1100.0%$35.98
0
2025-Q1
New
5,760
-
$102,9600.0%$17.88
33

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used